Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume

British Journal of Cancer

Volumn 82, Issue 5, 2000, Pages 1004-1008

  Davies, M M ^a   Jonas, S K ^a   Kaur, S ^a   Allen Mersh, T G ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Angiogenesis; bFGF; Colorectal cancer; Tumour volume; VEGF

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ARTICLE; BIOPSY; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIVER METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR VASCULARIZATION; TUMOR VOLUME; VASCULARIZATION;

EID: 0034010603     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1033     Document Type: Article

References (30)

1. Aherne WA and Dunnill MS (1982) Morphometry, pp. 60-73. Edward Arnold: London
2. Allen-Mersh TG, Earlam S, Fordy C, Abrams K and Houghton J (1994) Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet 344: 1255-1260
3. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C and Selby PJ (1998) Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77: 956-964
4. Basilico C and Moscatelli D (1992) The FGF family of growth factors and oncogenes. Adv Cancer Res 59: 115-165
5. Chalkley HW (1943) Method for the quantitative morphological analysis of tissue. J Natl Cancer Inst 4: 47-53
6. Dirix LY, Vermeulen PB, Hubens G, Benoy I, Martin M, DePooter C and Van Oosterom AT (1996) Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann Oncol 7: 843-848
7. Dirix LY, Vermeulen PB, Pawinski A, Prove A, Benoy I, De Pooter C, Martin M and Van Oosterom AT (1997) Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 76: 238-243
8. Dworkin MJ, Burke D, Earlam S, Fordy C and Allen-Mersh TG (1995) Measurement of response to treatment in colorectal liver metastases. Br J Cancer 71: 873-876
9. Eisma RJ, Spiro JD and Kreutzer DL (1997) Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. Am J Surg 174: 513-517
10. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
11. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC and Harris AL (1995) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177: 275-283
12. Fujimoto K, Ichimori Y, Kakizoe T, Okajima E, Sakamoto H, Sugimura T and Terada M (1991) Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem Biophys Res Commun 180: 386-392
13. Fujisaki K, Mitsuyama K, Toyonaga A, Matsuo K and Tanikawa K (1998) Circulating vascular endothelial growth factor in patients with colorectal cancer. Am J Gastroenterol 93: 249-252
14. Gasparini G and Harris AL (1995) Clinical importance of the determination of tumor angiogenesis in breast carcinoma; much more than a new prognostic tool. J Clin Oncol 13: 765-782
15. Kang S-M, Maeda K, Chung Y-S, Onoda N, Ogawa Y, Takatsuka S, Ogawa M, Sawada T, Kakata B, Nishiguchi Y, Ikehara T, Okuno M and Sowa M (1997) Vascular endothelial growth factor expression correlates with hematogenous metastasis and prognosis in colorectal carcinoma. Oncol Rep 4: 381-384
16. Kondo S, Asano M, Matsuo K, Ohmori I and Suzuki H (1994) Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta 1221: 211-214
17. Kumar H, Heer K, Lee PWR, Duthie GS, MacDonald AW, Greenman J, Kerin MJ and Monson JRT (1998) Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 4: 1279-1285
18. Landriscina M, Cassano A, Ratto C, Longo R, Ippoliti M, Palazzotti B, Crucitti F and Barone C (1998) Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. Br J Cancer 78: 765-770
19. Leung DW, Cachianes G, Kuang W-J, Goeddel DV and Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309
20. Maeda K, Chung YS and Ogawa Y (1996) Prognostic value of vascular endothelial growth factor for gastric carcinoma. Cancer 77: 858-863
21. Mayers MM, Seshadri R, Raymond W, McCaul K and Horsfall DJ (1998) Tumour microvascularity has no independent prognostic significance for breast cancer. Pathology 30: 105-110
22. Meyer GE, Yu E, Siegal JA, Petteway JC, Blumenstein BA and Brawer MK (1995) Serum basic fibroblast growth factor in men with and without prostate carcinoma. Cancer 76: 2304-2311
23. Senger DR, Van De Walter L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM and Dvorak HF (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12: 303-324
24. Sluitz G, Tempfer C, Obermair A, Reinthaller A, Gitsch G and Kainz C (1995a) Serum evaluation of basic fibroblast growth factor in cervical cancer patients. Cancer Lett 94: 227-231
25. Sluitz G, Tempfer C, Obermair A, Dadak C and Kainz C (1995b) Serum evaluation of basic fibroblast growth factor in breast cancer patients. Anticancer Res 15: 2675-2678
26. Takahashi Y, Kitadai Y and Bucana CZ (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res 55: 3964-3968
27. Terayama N, Terada T and Nakanuma Y (1996) An immunohistochemical study of tumour vessels in metastatic liver cancers and the surrounding liver tissue. Histopathology 29: 37-43
28. Weidner N (1998) Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow [editorial comment]. J Pathol 184: 119-122
29. Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T and Tominaga T (1996) Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 2: 821-826
30. Yamamoto S, Koishi I, Kuroda H, Komatsu T, Nanbu K, Sakahara H and Mori T (1997) Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival and analysis of serum VEGF levels. Br J Cancer 76: 1221-1227